Literature DB >> 507094

Fatty liver hepatitis and cirrhosis in obese patients.

M Adler, F Schaffner.   

Abstract

Liver function and liver biopsy findings were studied in a selected group of 29 overweight patients. Fatty liver, fatty hepatitis, fatty fibrosis and fatty cirrhosis were seen with equal frequency. Diabetes was also present with an equal incidence in each of these four pathologic groups. Lipoprotein abnormalities, particularly type IV hyperlipoproteinemia, were found mostly in the two groups with the lesions with less fibrosis (fatty liver and fatty hepatitis). The pathologic picture resembled that of alcohol and postjejunoileal bypass-induced liver diseases suggesting a common denominator in these three conditions.

Entities:  

Mesh:

Year:  1979        PMID: 507094     DOI: 10.1016/0002-9343(79)90740-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  66 in total

Review 1.  Histopathology of nonalcoholic fatty liver disease.

Authors:  Elizabeth M Brunt; Dina G Tiniakos
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

2.  Doppler waveform of the hepatic veins in an obese population.

Authors:  Nevzat Karabulut; Selçuk Kazil; Baki Yagci; Nuran Sabir
Journal:  Eur Radiol       Date:  2004-07-22       Impact factor: 5.315

Review 3.  Non-alcoholic fatty liver disease: an emerging pathological spectrum.

Authors:  Elie Serge Zafrani
Journal:  Virchows Arch       Date:  2003-12-18       Impact factor: 4.064

Review 4.  Nonalcoholic steatohepatitis in children.

Authors:  Eve A Roberts
Journal:  Curr Gastroenterol Rep       Date:  2003-06

5.  Non-invasive means of measuring hepatic fat content.

Authors:  Sanjeev-R Mehta; E-Louise Thomas; Jimmy-D Bell; Desmond-G Johnston; Simon-D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

Review 6.  Drug disposition in obese humans. An update.

Authors:  D R Abernethy; D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  1986 May-Jun       Impact factor: 6.447

7.  Clinicopathologic study of alcohol-like liver disease in non-alcoholics; non-alcoholic steatohepatitis and fibrosis.

Authors:  A Nonomura; Y Mizukami; M Unoura; K Kobayashi; Y Takeda; R Takeda
Journal:  Gastroenterol Jpn       Date:  1992-08

8.  Influence of obesity on sulfonamide disposition in Zucker rats.

Authors:  S Kaul; W A Ritschel
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Oct-Dec       Impact factor: 2.441

9.  Liver injury following jejunoileal bypass. Are there markers?

Authors:  S M Nasrallah; C E Wills; J T Galambos
Journal:  Ann Surg       Date:  1980-12       Impact factor: 12.969

10.  "Nonalcoholic steatohepatitis" induced by massive doses of synthetic estrogen.

Authors:  K Seki; Y Minami; M Nishikawa; S Kawata; S Miyoshi; Y Imai; S Tarui
Journal:  Gastroenterol Jpn       Date:  1983-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.